FEATURED
Less than 1 min.Read

BD Announces BD Kiestra ReadA is Now Available to U.S. Clinical Microbiology Laboratories

BD Kiestra™ ReadA, Available as a Standalone Instrument, Helps Improve Operational Efficiency in Clinical Microbiology Laboratories by Automating Routine Plate Management Tasks and Delivers Accuracy Through Standardized Digital Image Acquisition

The BD Kiestra ReadA provides closed door incubation and high throughput imaging to streamline workflow, delivering high quality images for digital interpretation by laboratory staff.

By reducing the time spent sorting plates combined with high resolution imaging, the system helps enhance operational efficiency and may reduce time to result.

“Building on the landmark CE marking of BD Kiestra™ IdentifA in November, we continue to execute on our strategy of modular laboratory automation solutions. The BD Kiestra™ ReadA instrument is a first-to-market solution that will enable new customers to enter microbiology lab automation at the incubation and imaging step,” said Steve Conly, vice president of microbiology at BD. “The system transforms the manual, hands-on workflow of plate-reading to one that is automated and digital.”

Powered by BD Synapsys™ microbiology informatics solution, the BD Kiestra™ ReadA also provides on-demand patient summary overviews, allowing lab staff to access actionable information from anywhere, any time.

BD continues to invest in automation and innovation for the microbiology laboratory. For more information on BD Kiestra™ lab automation solutions, please visit https://www.bd.com/en-us/offerings/capabilities/lab-automation.

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

0
Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

0
EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

0
The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

0
Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

0
Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York, No. Carolina
United States
Phone Number: 1.561.316.3330